10/29/2026
New York State's guidelines currently describe babesiosis as a very rare risk of transfusion.
However, the patients receiving transfusions are often those at the highest risk for severe disease, including the elderly, immunocompromised individuals, critically ill patients, and neonates. So, what can we do, as laboratory and health care professionals, to provide a safer blood supply for some of the most vulnerable members within our communities?
🩸 The FDA recommends nucleic acid testing of blood donations in high-risk states, including New York.
🩸 Reporting is key: for example, any transfusion-related case must be reported to the collecting facility and the Blood Tissue Resources Program.
❓ What are some of the ways you are working to fight the threat of ? Share in the comments!
Then, check out the full podcast episode with Dr. Kevin Dell’Aquila to learn more! Link in comments.